RRT Configuration Does Not Impact Complication Rates in VA-ECMO Patients

Renal Support Strategies in Extracorporeal Membrane Oxygenation

Acute kidney injury (AKI) frequently complicates the clinical course of patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO), often driven by the systemic inflammatory response and multiorgan failure [1, 2]. Managing renal replacement therapy (RRT), which involves the extracorporeal filtration of blood to manage fluid and solute clearance, presents significant technical hurdles in these hemodynamically unstable patients [3, 4]. Clinicians must navigate the risks of vascular access, including catheter-related bloodstream infections and hemorrhagic events, while maintaining the integrity of the extracorporeal circuit [5]. While the timing and modality of renal support remain debated, a recent retrospective analysis evaluates how different circuit configurations influence safety outcomes in this critically ill population [4, 6].

Comparing Integrated and Parallel Circuit Designs

Physicians managing patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) typically choose between two primary configurations for renal support. Renal replacement therapy (RRT) can be delivered via a separate indwelling catheter, known as a parallel system (PS), or through a direct connection to the existing ECMO circuit, referred to as an integrated system (IS). To assess the safety profiles of these approaches, researchers conducted a single-center retrospective analysis of prospectively collected data from 80 consecutive adults who received renal replacement therapy for at least 24 hours while on VA-ECMO support between 2006 and 2019. The study analyzed 84 distinct procedures, which were divided equally into 42 integrated system (IS) procedures and 42 parallel system (PS) procedures. This cohort allowed for a direct comparison of complications occurring during the concomitant ECMO-RRT period, defined as the timeframe when both extracorporeal circuits were operating simultaneously.

Infectious and Hemorrhagic Outcomes

The analysis of infectious complications revealed that 31% of integrated system (IS) procedures resulted in an infection, compared to 45.2% of parallel system (PS) procedures. Although the raw incidence was higher in the parallel group, the researchers identified a significant difference in the timing of these events. Infectious complications had a statistically significant earlier onset in the parallel system (PS) group, occurring at a median of 3 days compared to 5 days in the integrated system (IS) group (p = 0.048). This earlier onset likely reflects the additional risk introduced by the insertion of a separate indwelling venous catheter. However, when the researchers applied a multivariable analysis (a statistical technique used to adjust for confounding factors and isolate the specific impact of the circuit configuration), the integrated system (IS) was not independently associated with a reduced risk of infection, yielding an odds ratio of 0.67 (95% CI, 0.27 to 1.70; p = 0.421). Hemorrhagic outcomes were also similar between the two groups, with hemorrhagic events occurring in 54.8% of integrated system (IS) procedures and 59.5% of parallel system (PS) procedures, suggesting that the method of renal support does not significantly alter the high baseline bleeding risk inherent to extracorporeal support.

Clinical Implications for Intensive Care Management

Acute kidney injury (AKI) in the setting of venoarterial extracorporeal membrane oxygenation (VA-ECMO) is primarily a consequence of severe cardiogenic shock and subsequent multiorgan failure, which severely compromise renal perfusion. Because these patients are already at high risk for adverse events, the choice between an integrated system (IS) and a parallel system (PS) for renal replacement therapy (RRT) must be guided by circuit stability and patient safety. The study found that circuit dysfunctions, including filter clotting, were comparable between the two groups, indicating that neither the direct circuit connection nor the independent catheter provides a superior mechanical advantage for maintaining filter patency. Furthermore, the data demonstrated that integrated and parallel configurations have similar safety profiles, with no significant differences observed in infectious, hemorrhagic, or circuit-related complications. For the practicing intensivist, these findings suggest that the physiological burden of the extracorporeal circuit itself is the primary driver of morbidity, rather than the specific renal replacement therapy (RRT) interface. Consequently, the researchers conclude that the findings support selecting the renal replacement therapy (RRT) configuration based primarily on local expertise and technical feasibility. Clinical teams should utilize the configuration that best aligns with institutional protocols and the technical proficiency of the bedside staff rather than expecting one modality to reduce the risk of major complications.

References

1. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. 2021. doi:10.1097/ccm.0000000000005337

2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky PM, workgroup TA. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care. 2004. doi:10.1186/cc2872

3. Russo DS, Eugenio CS, Balestrin IG, et al. Comparison of hemodynamic instability among continuous, intermittent and hybrid renal replacement therapy in acute kidney injury: A systematic review of randomized clinical trials.. Journal of critical care. 2022. doi:10.1016/j.jcrc.2022.153998

4. Zhou X, Dong P, Pan J, Wang H, Xu Z, Chen B. Renal replacement therapy modality in critically ill patients with acute kidney injury - A network meta-analysis of randomized controlled trials.. Journal of critical care. 2021. doi:10.1016/j.jcrc.2021.03.011

5. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-related Infections. Clinical Infectious Diseases. 2011. doi:10.1093/cid/cir257

6. Zhang L, Chen D, Tang X, Li P, Zhang Y, Tao Y. Timing of initiation of renal replacement therapy in acute kidney injury: an updated meta-analysis of randomized controlled trials.. Renal failure. 2020. doi:10.1080/0886022X.2019.1705337